Oncolytics Biotech (ONCY) Expected to Announce Quarterly Earnings on Friday

Oncolytics Biotech (NASDAQ:ONCY) is projected to release its earnings data before the market opens on Friday, March 7th. Analysts expect Oncolytics Biotech to post earnings of ($0.08) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Oncolytics Biotech Stock Performance

Shares of NASDAQ:ONCY opened at $0.74 on Thursday. The firm has a market capitalization of $63.09 million, a PE ratio of -2.73 and a beta of 1.18. The firm has a fifty day moving average of $0.80 and a 200 day moving average of $0.94. Oncolytics Biotech has a 52-week low of $0.60 and a 52-week high of $1.53.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Leede Financial downgraded shares of Oncolytics Biotech from a “strong-buy” rating to a “moderate buy” rating in a research note on Wednesday, November 13th. HC Wainwright restated a “buy” rating and set a $5.00 price objective on shares of Oncolytics Biotech in a research report on Monday, February 3rd. Finally, Raymond James upgraded shares of Oncolytics Biotech to a “moderate buy” rating in a research report on Thursday, November 14th.

About Oncolytics Biotech

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.